C

    CERo Therapeutics Holdings, Inc. Common Stock (CERO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.01
    +0.00 (+6.00%)

    Market Cap: $787,940

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    33%(1/3)
    Avg Surprise
    -309.86%

    Upcoming Estimates

    Mar 31, 2026
    EPS Consensus$-1.00
    Range$-1.00 - $-1.00
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-1.00
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Jun 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-N/A---
    Mar 26EST
    		-$-1.00---
    Dec 25
    		$N/A$-0.75N/ABeat-
    Sep 25
    		$-9.10$-4.35-109.20%Miss+94.7%
    Jun 25
    		$-61.71$-6.21-893.72%Miss+79.6%
    Mar 25
    		$-31.80N/A+73.32%Beat+89.8%
    Dec 24
    		$-17.49N/AN/ABeat+80.7%
    Sep 24
    		$-170.22N/AN/ABeat-61.4%
    Jun 24
    		$-302.32N/AN/ABeat+28.0%
    Mar 24
    		$-312.74N/AN/ABeat-119.7%
    Dec 23
    		$-90.54N/AN/ABeat-905281.0%
    Sep 23
    		$-105.50N/AN/ABeat-1534.5%
    Jun 23
    		$-419.78N/AN/ABeat-4223.4%
    Mar 23
    		$-142.32N/AN/ABeat-711486.5%
    Dec 22
    		$-0.01N/AN/ABeat+0.0%
    Sep 22
    		$7.35N/AN/ABeat+73643.0%
    Jun 22
    		$-9.71N/AN/ABeat-
    Mar 22
    		$-0.02N/AN/ABeat-
    Dec 21
    		$-0.01N/AN/ABeat-
    Sep 21
    		$-0.01$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.00EV/EBITDAN/A
    Price/FCF-0.04xFCF Yield-2711.13%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE0.00%ROIC42.09%
    Financial Health
    Debt/Equity-0.02xInterest CoverageN/A
    Current Ratio0.05xQuick Ratio0.05x
    Trading Statistics
    Beta0.16Avg Volume467.53K
    52-Week High$7.6052-Week Low$0.01

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.01
    SMA 20$0.01
    SMA 50$0.01
    SMA 200$0.04
    EMA 10$0.01
    EMA 20$0.01
    EMA 50$0.01
    EMA 200$1.60

    MACD

    Line: -0.00Signal: -0.00Hist: 0.00

    ADX

    ADX: 10.7+DI: 16.3-DI: 16.1

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down28.0
    PSAR$0.01

    Bollinger Bands

    Upper Band$0.01
    Lower Band$0.01
    %B Position3620%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    50.7

    Momentum Oscillators

    Stoch %K31.7
    Stoch %D22.0
    Williams %R-56.7
    ROC (10d)-5.4%
    Momentum-0.00
    CCI (20d)7.1
    MFI (14d)46.3

    Volatility Measures

    ATR (14d)$0.00(19.9%)
    StdDev (20d)0.00
    Hist Vol167.9%(High)

    Volume Flow

    VWAP$0.01
    OBV-1.6M
    AD Line24.9B
    CMF (20d)-0.254

    Volume Metrics

    Avg Vol (20d)487.1K
    Vol Ratio0.1x(Low)
    VWMA (20d)$0.01

    Pivot Points

    R3$0.01
    R2$0.01
    R1$0.01
    Pivot Point$0.01
    S1$0.01
    S2$0.01
    S3$0.01

    Advanced Oscillators

    TSI-6.01
    Ultimate Osc40.9
    KST-56.12

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$0$0N/A$0$0$0$0$0N/A$0$0$0
    Cost of Revenue$0$0N/A$0$0$0$0$0$288,161$284,751$0$0
    Gross Profit$0$0N/A$0$0$0$0$0$-288,161$-284,751$0$0
    Operating Expenses$3.85M$4.85M$4.43M$4.36M$4.72M$4.95M$4.40M$5.15M$4.26M$1.35M$1.54M$2.41M
    R&D$1.74M$2.34M$2.33M$2.39M$2.75M$2.91M$1.77M$2.71M$1.38M$1.02M$1.28M$1.19M
    SG&A$2.11M$2.51M$2.09M$1.98M$1.97M$2.04M$2.63M$2.43M$2.88M$331,629$258,013$1.22M
    Operating Income$-3,846,466$-4,845,728$-4,426,248$-4,362,579$-4,723,791$-4,950,531$-4,402,238$-5,148,237$-4,552,070$-1,287,386$-1,535,571$-2,413,746
    Interest Income$1,025$3,149$-8,948$5,936$13,776$850$4,418$-16,977$0$0$0$0
    Interest Expense$690,044$166,286$114,373$500,000$0$0$0$0$9,629$-78,750$-157$-59,417
    Income Before Tax$-1,028,830$-5,885,914$-4,540,621$-4,856,395$-5,417,315$-5,105,931$-4,227,967$-2,448,654$-2,299,694$-1,347,227$-1,349,347$-2,092,507
    Income Tax Expense$0$0$0$0$0$0$0$0$-1$0$0$0
    Net Income$-1,028,830$-5,885,914$-4,540,621$-4,856,395$-5,417,315$-5,105,931$-4,227,967$-2,448,654$-2,299,694$-1,409,393$-1,349,347$-2,092,507
    EBITDA$114,130$-5,309,870$-4,150,118$-4,089,565$-5,554,851$-4,837,306$-4,232,385$-2,431,677$-2,001,904$-1,141,226$-1,068,092$-1,874,473
    EBIT$-339,811$-5,722,777$-4,426,254$-4,362,331$-5,431,091$-5,106,781$-4,232,385$-2,431,677$-2,290,065$-1,425,977$-1,349,504$-2,151,924
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CERO

    News

    No news available

    Company news will appear here when available

    Frequently Asked Questions About CERO

    Does CERO pay dividends?
    CERo Therapeutics Holdings, Inc. Common Stock (CERO) does not currently pay a regular dividend.
    What is CERO's market cap?
    CERo Therapeutics Holdings, Inc. Common Stock (CERO) has a market capitalization of $787,940 with a current stock price of $0.01.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In